MedTrace Logo

Muscle Characteristics Associated With Statin Therapy

NCT00990834 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-05-22

No results posted yet for this study

Summary

The purpose of this study is to investigate the mechanism of statin-related myopathy by evaluating muscle samples before and after statin exposure.

Conditions

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Myopathy

Interventions

DRUG

simvastatin

simvastatin 80 mg PO daily for one to eight months.

Sponsors & Collaborators

  • Scripps Health

    lead OTHER

Principal Investigators

  • Tam H Truong, MD · Scripps Health

  • Paul S Phillips, MD · Scripps Health

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00990834 on ClinicalTrials.gov